NewYorkBio/NYSE Emerging Biotech Company Showcase

MedNous article: A surprise finding in the clinic

Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic

Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients

Interview with Ella Radvogin, Clinical Psychologist at Alex Therapeutics

Idiopathic Pulmonary Fibrosis: 5 Things to Know